Cargando…
Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population
PURPOSE: Considering the cross-protection reported for bacillus Calmette-Guérin (BCG) vaccination on viral respiratory infections, it has been proposed that it could reduce the severity of coronavirus disease 2019 (COVID-19). The objective of the current study is to investigate the association betwe...
Autores principales: | Khanum, Iffat, Kumar, Lokesh, Awan, Safia, Jamil, Bushra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511583/ https://www.ncbi.nlm.nih.gov/pubmed/34703811 http://dx.doi.org/10.7774/cevr.2021.10.3.276 |
Ejemplares similares
-
A possible protective role for Bacillus Calmette-Guérin therapy in urinary bladder cancer in the era of COVID-19: a brief report
por: Ohadian Moghadam, Solmaz, et al.
Publicado: (2021) -
Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG): Case Report
por: Luciani, Michelangelo, et al.
Publicado: (2020) -
Current national policies for infant universal bacille Calmette-Guérin vaccination were associated with lower mortality from coronavirus disease 2019
por: Ebina-Shibuya, Risa, et al.
Publicado: (2020) -
Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates
por: Behr, Marcel A, et al.
Publicado: (2020) -
Bacillus Calmette-Guerin (BCG) vaccine in Iran
por: Fallah, Fatemeh, et al.
Publicado: (2018)